Embolization of Pseudoaneurysms is Associated With Improved Outcomes in Blunt Splenic Trauma.
Male
Humans
Retrospective Studies
Aneurysm, False
/ diagnostic imaging
Prostate-Specific Antigen
Spleen
/ injuries
Splenectomy
Wounds, Nonpenetrating
/ complications
Abdominal Injuries
/ complications
Embolization, Therapeutic
/ methods
Splenic Artery
/ diagnostic imaging
Treatment Outcome
Injury Severity Score
Angioembolization
Angiography
Blunt splenic trauma
Pseudoaneurysm
Spleen
Journal
The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340
Informations de publication
Date de publication:
01 2024
01 2024
Historique:
received:
28
02
2023
revised:
27
07
2023
accepted:
27
08
2023
medline:
24
11
2023
pubmed:
15
10
2023
entrez:
15
10
2023
Statut:
ppublish
Résumé
The necessity of angioembolization for all splenic pseudoaneurysms (PSAs) is unknown after blunt trauma. We compared the outcomes of patients with PSAs managed with splenic artery embolization (EMBO) versus no embolization (NO-EMBO). We retrospectively reviewed all patients with blunt splenic trauma and PSA on initial computed tomography scan admitted to an academic, urban, Level I trauma center from 2016 to 2021. Patients who had emergent splenectomy or died before discharge were excluded. Demographics, injury and computed tomography characteristics, and details regarding angiography, if pursued, were collected. The primary outcome was failure of nonoperative management (FNOM), as defined by need for delayed splenectomy for the EMBO group versus delayed splenectomy or embolization for the NO-EMBO group. One hundred and fifty-six patients were in the final study population, of which 96 (61.5%) were in the EMBO group and 60 (38.5%) were in the NO-EMBO group. Patient demographics and mechanism of injury were similar between the two cohorts. The two cohorts had similar imaging findings, however, EMBO patients had more compartments with hemoperitoneum (2 versus 1, P < 0.01). Patients who underwent embolization had a lower FNOM rate (3.1% versus 13.3%, P = 0.02). Splenic artery embolization in the setting of PSA is associated with lower rates of FNOM versus nonembolization. It is unclear if addressing the PSA itself with embolization drives the decreased FNOM rate.
Identifiants
pubmed: 37839096
pii: S0022-4804(23)00483-3
doi: 10.1016/j.jss.2023.08.054
pii:
doi:
Substances chimiques
Prostate-Specific Antigen
EC 3.4.21.77
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
656-662Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.